
Clene Inc.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Clene Inc. is a clinical-stage biopharmaceutical company developing nanocrystalline gold, platinum, and other metal-based drug candidates to treat neurodegenerative diseases such as ALS and multiple sclerosis.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| WILCOX REED NDirector | Buy | $27K | 8,000at $3.42 | Nov 18, 2026 |
| WILCOX REED NDirector | Buy | $7K | 2,000at $3.44 | Nov 18, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable CLNN activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.